Edoxaban

Edoxaban is a direct oral anticoagulant (blood thinner) used to lower stroke risk in Afib. It works by reducing clot formation in the bloodstream. Tracking your use and any changes you notice may help you stay informed about your treatment.

Your data

This graph shows how your Quality of Life (QoL) has been affected by this treatment in the past 30 days.

Community insights

Average duration of this treatment
Hours
Gender of members that
reported this trigger
50.0%
0.0%
50.0%
The age of our members that
reported this treatment
Members' top five risk factors
COVID-19 / Influenza 75%
Coronary Artery Disease (CAD) 50%
Obesity 50%
Pericarditis 25%
Hypothyroidism (Underactive Thyroid) 25%
Effect of this treatment
on quality of life
Quality of Life Gauge
QoL: 2.7
Number of members who reported this treatment
4
What type of Afib members who reported this treatment have
  • Paroxysmal
  • Persistent
  • Long-standing persistent
  • Permanent

Other treatments

The percentage of reporters who reported this specific treatment
Flecainide 52.9%
Metoprolol 29.4%
Electrical Cardioversion 23.5%
Catheter Ablation 17.6%
Rivaroxaban 11.8%
Amiodarone 5.9%
Apixaban 5.9%
Bisoprolol 5.9%
Cryoballoon Ablation 5.9%
Dabigatran 5.9%
Diltiazem 5.9%
Radiofrequency Ablation 5.9%